Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Retinoblastoma × Filgrastim × Clear all

Phase

Phase 2 7 Phase 1 4 Phase 3 2 Phase NA 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 14 Lymphoma 12 Lymphoma, Large B-Cell, Diffuse 11 Lymphoma, Non-Hodgkin 10 Lymphoma, Mantle-Cell 10 Lymphoma, Large-Cell, Immunoblastic 10 Lymphoma, Follicular 10 Burkitt Lymphoma 10 Leukemia, Myeloid, Acute 9 Leukemia, Lymphocytic, Chronic, B-Cell 9 Lymphoma, B-Cell, Marginal Zone 8 Leukemia, Myeloid, Chronic-Phase 8 Leukemia 8 Congenital Abnormalities 8 Myelodysplastic Syndromes 7 Multiple Myeloma 7 Leukemia, Myeloid, Accelerated Phase 7 Myeloproliferative Disorders 6 Hodgkin Disease 6 Blast Crisis 6 Recurrence 5 Primary Myelofibrosis 5 Lymphoma, T-Cell, Cutaneous 5 Leukemia, Hairy Cell 5 Dendritic Cell Sarcoma, Interdigitating 5 Sezary Syndrome 4 Pdgfra-Associated Chronic Eosinophilic Leukemia 4 Neoplasms, Plasma Cell 4 Mycosis Fungoides 4 Leukemia, Neutrophilic, Chronic 4

Interventions

Carboplatin 4 Melphalan 3 Vincristine 2 Etoposide 2 etoposide phosphate 1 Watchful Waiting 1 Ursodeoxycholic Acid 1 Topotecan 1 Thiotepa 1 Saline Solution 1 Radiotherapy 1 Radiation 1 Photochemotherapy 1 Paclitaxel 1 Nitroglycerin 1 Neoadjuvant Therapy 1 Mesna 1 Leukapheresis 1 Ifosfamide 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Dexmedetomidine 1 Cytarabine 1 Cryotherapy 1 Chemotherapy, Adjuvant 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00980551 2017-03-03

RELRB1

Children's Hospital Medical Center, Cincinnati

Phase NA Withdrawn

Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡